Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Twist Bioscience announces SARS-CoV-2 neutralizing data from antibody program » 08:13
09/02/20
09/02
08:13
09/02/20
08:13
TWST

Twist Bioscience

$71.62 /

+1.53 (+2.18%)

Twist Bioscience…

Twist Bioscience announced data demonstrating the neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G, or IgG, antibodies and substantially smaller single domain VHH "nanobodies," against SARS-CoV-2, the virus that causes COVID-19. These neutralizing effects were found to be comparable to or better than those seen with antibody candidates derived from patients who had recovered from COVID-19. The data were collected from studies conducted by Saint Louis University and independently verified by scientists at Colorado State University. The in vitro studies involved testing more than 200 well characterized monoclonal antibody and VHH nanobody candidates against live virus and pseudovirus cells. Each antibody was chosen for its high and unbiased binding affinity to either the receptor binding domain of the S1 protein of SARS-CoV-2 or the extracellular domain of ACE2 in human cells. The candidates were identified by Twist Biopharma, a division of Twist Bioscience, in just six weeks by screening its proprietary synthetic antibody discovery libraries each containing more than 10B antibody sequences, and within months produced robust neutralization data in live virus cells.

ShowHide Related Items >><<
TWST Twist Bioscience
$71.62 /

+1.53 (+2.18%)

TWST Twist Bioscience
$71.62 /

+1.53 (+2.18%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$71.62 /

+1.53 (+2.18%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$71.62 /

+1.53 (+2.18%)

Over a month ago
Conference/Events
UBS to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
ADPT

Adaptive Biotechnologies

$38.34 /

+1.56 (+4.24%)

, BX

Blackstone

$52.85 /

+0.38 (+0.72%)

, BDX

Becton Dickinson

$257.24 /

+2.24 (+0.88%)

, GH

Guardant Health

$86.82 /

+5.17 (+6.33%)

, ILMN

Illumina

$344.15 /

+3.03 (+0.89%)

, MASI

Masimo

$211.09 /

+1.56 (+0.74%)

, NVTA

Invitae

$29.76 /

+0.775 (+2.67%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, TWST

Twist Bioscience

$62.31 /

+6.72 (+12.09%)

, TXG

10x Genomics

$97.75 /

+0.97 (+1.00%)

Genomics 2.0 Virtual…

Genomics 2.0 Virtual Conference will be held on August 11-13.Webcast Link

ShowHide Related Items >><<
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
BX Blackstone
$52.85 /

+0.38 (+0.72%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
GH Guardant Health
$86.82 /

+5.17 (+6.33%)

08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
ILMN Illumina
$344.15 /

+3.03 (+0.89%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 Evercore ISI
Illumina downgraded to Underperform from In Line at Evercore ISI
08/07/20 Piper Sandler
Illumina downgraded to Neutral from Overweight at Piper Sandler
07/07/20 Guggenheim
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim
MASI Masimo
$211.09 /

+1.56 (+0.74%)

04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
03/02/20 Raymond James
Masimo 'well positioned' should COVID-19 expand, says Raymond James
NVTA Invitae
$29.76 /

+0.775 (+2.67%)

08/05/20 SVB Leerink
Invitae price target lowered to $34 from $40 at SVB Leerink
08/05/20 Ladenburg
Invitae price target raised to $37.25 from $31.25 at Ladenburg
07/22/20 Oppenheimer
Invitae price target raised to $37 from $29 at Oppenheimer
07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
TNDM TNDM
/

+

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stifel
10x Genomics initiated with a Buy at Stifel
05/12/20 Cowen
10x Genomics price target raised to $85 from $68 at Cowen
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

  • 16
    Jul
  • 04
    Jun
  • 02
    Jun
  • 21
    May
  • 02
    Apr
  • 20
    Feb
  • 24
    Jan
  • 12
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

Conference/Events
UBS to hold a virtual conference » 04:55
08/12/20
08/12
04:55
08/12/20
04:55
ADPT

Adaptive Biotechnologies

$36.78 /

-0.82 (-2.18%)

, BX

Blackstone

$52.47 /

+0.175 (+0.33%)

, BDX

Becton Dickinson

$255.00 /

-1.75 (-0.68%)

, GH

Guardant Health

$81.65 /

-4.3 (-5.00%)

, ILMN

Illumina

$341.12 /

-12.19 (-3.45%)

, MASI

Masimo

$209.53 /

-1.96 (-0.93%)

, NVTA

Invitae

$28.98 /

+0.17 (+0.59%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, TWST

Twist Bioscience

$55.59 /

-4.17 (-6.98%)

, TXG

10x Genomics

$96.78 /

+0.01 (+0.01%)

Genomics 2.0 Virtual…

Genomics 2.0 Virtual Conference will be held on August 11-13.Webcast Link

ShowHide Related Items >><<
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
BX Blackstone
$52.47 /

+0.175 (+0.33%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
GH Guardant Health
$81.65 /

-4.3 (-5.00%)

08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
ILMN Illumina
$341.12 /

-12.19 (-3.45%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 Evercore ISI
Illumina downgraded to Underperform from In Line at Evercore ISI
08/07/20 Piper Sandler
Illumina downgraded to Neutral from Overweight at Piper Sandler
07/07/20 Guggenheim
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim
MASI Masimo
$209.53 /

-1.96 (-0.93%)

04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
03/02/20 Raymond James
Masimo 'well positioned' should COVID-19 expand, says Raymond James
NVTA Invitae
$28.98 /

+0.17 (+0.59%)

08/05/20 SVB Leerink
Invitae price target lowered to $34 from $40 at SVB Leerink
08/05/20 Ladenburg
Invitae price target raised to $37.25 from $31.25 at Ladenburg
07/22/20 Oppenheimer
Invitae price target raised to $37 from $29 at Oppenheimer
07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
TNDM TNDM
/

+

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stifel
10x Genomics initiated with a Buy at Stifel
05/12/20 Cowen
10x Genomics price target raised to $85 from $68 at Cowen
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

  • 16
    Jul
  • 04
    Jun
  • 02
    Jun
  • 21
    May
  • 02
    Apr
  • 20
    Feb
  • 24
    Jan
  • 12
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

Conference/Events
UBS to hold a virtual conference » 08:31
08/11/20
08/11
08:31
08/11/20
08:31
ADPT

Adaptive Biotechnologies

$37.60 /

-0.64 (-1.67%)

, BX

Blackstone

$52.30 /

-0.215 (-0.41%)

, BDX

Becton Dickinson

$256.75 /

+0.425 (+0.17%)

, GH

Guardant Health

$85.95 /

+0.16 (+0.19%)

, ILMN

Illumina

$353.31 /

-2.35 (-0.66%)

, MASI

Masimo

$211.49 /

-5.91 (-2.72%)

, NVTA

Invitae

$28.81 /

+0.39 (+1.37%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, TWST

Twist Bioscience

$59.76 /

-1.95 (-3.16%)

, TXG

10x Genomics

$96.77 /

+0.4 (+0.42%)

Genomics 2.0 Virtual…

Genomics 2.0 Virtual Conference will be held on August 11-13.Webcast Link

ShowHide Related Items >><<
TXG 10x Genomics
$96.77 /

+0.4 (+0.42%)

TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.81 /

+0.39 (+1.37%)

MASI Masimo
$211.49 /

-5.91 (-2.72%)

ILMN Illumina
$353.31 /

-2.35 (-0.66%)

GH Guardant Health
$85.95 /

+0.16 (+0.19%)

BX Blackstone
$52.30 /

-0.215 (-0.41%)

BDX Becton Dickinson
$256.75 /

+0.425 (+0.17%)

ADPT Adaptive Biotechnologies
$37.60 /

-0.64 (-1.67%)

ADPT Adaptive Biotechnologies
$37.60 /

-0.64 (-1.67%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
BX Blackstone
$52.30 /

-0.215 (-0.41%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BDX Becton Dickinson
$256.75 /

+0.425 (+0.17%)

08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
GH Guardant Health
$85.95 /

+0.16 (+0.19%)

08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
ILMN Illumina
$353.31 /

-2.35 (-0.66%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 Evercore ISI
Illumina downgraded to Underperform from In Line at Evercore ISI
08/07/20 Piper Sandler
Illumina downgraded to Neutral from Overweight at Piper Sandler
07/07/20 Guggenheim
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim
MASI Masimo
$211.49 /

-5.91 (-2.72%)

04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
03/02/20 Raymond James
Masimo 'well positioned' should COVID-19 expand, says Raymond James
NVTA Invitae
$28.81 /

+0.39 (+1.37%)

08/05/20 SVB Leerink
Invitae price target lowered to $34 from $40 at SVB Leerink
08/05/20 Ladenburg
Invitae price target raised to $37.25 from $31.25 at Ladenburg
07/22/20 Oppenheimer
Invitae price target raised to $37 from $29 at Oppenheimer
07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
TNDM TNDM
/

+

07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
07/31/20 Guggenheim
Tandem Diabetes upgraded to Buy from Neutral at Guggenheim
TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TXG 10x Genomics
$96.77 /

+0.4 (+0.42%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stifel
10x Genomics initiated with a Buy at Stifel
05/12/20 Cowen
10x Genomics price target raised to $85 from $68 at Cowen
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
TXG 10x Genomics
$96.77 /

+0.4 (+0.42%)

TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.81 /

+0.39 (+1.37%)

MASI Masimo
$211.49 /

-5.91 (-2.72%)

ILMN Illumina
$353.31 /

-2.35 (-0.66%)

GH Guardant Health
$85.95 /

+0.16 (+0.19%)

BX Blackstone
$52.30 /

-0.215 (-0.41%)

BDX Becton Dickinson
$256.75 /

+0.425 (+0.17%)

ADPT Adaptive Biotechnologies
$37.60 /

-0.64 (-1.67%)

  • 16
    Jul
  • 04
    Jun
  • 02
    Jun
  • 21
    May
  • 02
    Apr
  • 20
    Feb
  • 24
    Jan
  • 12
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MASI Masimo
$211.49 /

-5.91 (-2.72%)

BX Blackstone
$52.30 /

-0.215 (-0.41%)

TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.81 /

+0.39 (+1.37%)

MASI Masimo
$211.49 /

-5.91 (-2.72%)

ILMN Illumina
$353.31 /

-2.35 (-0.66%)

GH Guardant Health
$85.95 /

+0.16 (+0.19%)

BX Blackstone
$52.30 /

-0.215 (-0.41%)

BDX Becton Dickinson
$256.75 /

+0.425 (+0.17%)

ADPT Adaptive Biotechnologies
$37.60 /

-0.64 (-1.67%)

NVTA Invitae
$28.81 /

+0.39 (+1.37%)

ILMN Illumina
$353.31 /

-2.35 (-0.66%)

BX Blackstone
$52.30 /

-0.215 (-0.41%)

Conference/Events
Twist Bioscience management to virtually meet with JPMorgan » 04:55
08/11/20
08/11
04:55
08/11/20
04:55
TWST

Twist Bioscience

$59.76 /

-1.95 (-3.16%)

Virtual Meetings to be…

Virtual Meetings to be held on August 10-11 hosted by JPMorgan.

ShowHide Related Items >><<
TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$59.76 /

-1.95 (-3.16%)

Conference/Events
Twist Bioscience management to virtually meet with JPMorgan » 04:55
08/10/20
08/10
04:55
08/10/20
04:55
TWST

Twist Bioscience

$61.71 /

-4 (-6.09%)

Virtual Meetings to be…

Virtual Meetings to be held on August 10-11 hosted by JPMorgan.

ShowHide Related Items >><<
TWST Twist Bioscience
$61.71 /

-4 (-6.09%)

TWST Twist Bioscience
$61.71 /

-4 (-6.09%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$61.71 /

-4 (-6.09%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$61.71 /

-4 (-6.09%)

Earnings
Twist Bioscience reports Q2 EPS (67c), consensus (73c) » 17:02
08/06/20
08/06
17:02
08/06/20
17:02
TWST

Twist Bioscience

$65.71 /

-0.83 (-1.25%)

Reports Q2 revenue…

Reports Q2 revenue $21.2M, consensus $14.2M. As of June 30, 2020, the company had $311.8 million in cash, cash equivalents and short term investments. "We posted a strong quarter of revenue growth for both synthetic biology and next generation sequencing (NGS) along with solid orders and a robust pipeline of opportunities across our silicon-based technology platform," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "Our disruptive platform combined with our unique business model continues to enable us to expand our footprint among our existing markets, extend our reach through biopharma partnerships and concurrently respond to pressing market needs including demand for COVID-19 related products."

ShowHide Related Items >><<
TWST Twist Bioscience
$65.71 /

-0.83 (-1.25%)

TWST Twist Bioscience
$65.71 /

-0.83 (-1.25%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$65.71 /

-0.83 (-1.25%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$65.71 /

-0.83 (-1.25%)

Conference/Events
Twist Bioscience management to virtually meet with JPMorgan » 10:04
08/04/20
08/04
10:04
08/04/20
10:04
TWST

Twist Bioscience

$59.19 /

+0.28 (+0.48%)

Virtual Meetings to be…

Virtual Meetings to be held on August 10-11 hosted by JPMorgan.

ShowHide Related Items >><<
TWST Twist Bioscience
$59.19 /

+0.28 (+0.48%)

TWST Twist Bioscience
$59.19 /

+0.28 (+0.48%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$59.19 /

+0.28 (+0.48%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$59.19 /

+0.28 (+0.48%)

Hot Stocks
Twist Bioscience, Seismic Bio partner for discovery, optimization of antibodies » 08:10
08/04/20
08/04
08:10
08/04/20
08:10
TWST

Twist Bioscience

$58.91 /

+2.74 (+4.88%)

Twist Bioscience and…

Twist Bioscience and Seismic Bio announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets. Under the terms of the agreement, Twist Biopharma, a division of Twist Bioscience, will use its proprietary Hyperimmune Libraries, two fully human antibody libraries focused on the heavy chain complementary determining region 3, or CDR3, loop diversity involved in antigen recognition, to identify antibodies that bind to the specified immuno-oncology targets. Seismic Bio will then use these monoclonal antibodies as building blocks to create bispecific antibody therapeutics. Seismic Bio will pay Twist technology activity fees as well as milestones for all compounds discovered through the agreement.

ShowHide Related Items >><<
TWST Twist Bioscience
$58.91 /

+2.74 (+4.88%)

TWST Twist Bioscience
$58.91 /

+2.74 (+4.88%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$58.91 /

+2.74 (+4.88%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$58.91 /

+2.74 (+4.88%)

Hot Stocks
Twist Bioscience launches 2 SARS-CoV-2 antibody panels to expedite research » 08:04
07/28/20
07/28
08:04
07/28/20
08:04
TWST

Twist Bioscience

$58.65 /

+4.02 (+7.36%)

Twist Bioscience said in…

Twist Bioscience said in a release, "Twist Bioscience announced the availability of two new SARS-CoV-2 antibody panels designed for research use only. The Twist anti-SARS-CoV-2 S1 Antibody Panel includes 32 human antibodies that bind with picomolar to nanomolar affinity to S1 spike protein on the SARS-CoV-2 virus, the virus that causes COVID-19. The Twist Human anti-ACE2 Antibody Panel includes 48 antibodies that bind with picomolar to nanomolar affinity to the extracellular domain, or ECD, of the ACE2 receptor on human cells, the receptor that facilitates entry of SARS-CoV-2 into the cells. All antibodies in each panel are cloned into human antibody backbones to generate VHH Fc, IgG1 or IgG2 antibodies."

ShowHide Related Items >><<
TWST Twist Bioscience
$58.65 /

+4.02 (+7.36%)

TWST Twist Bioscience
$58.65 /

+4.02 (+7.36%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$58.65 /

+4.02 (+7.36%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$58.65 /

+4.02 (+7.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.